About 908 Devices
908 Devices is a company based in Boston (United States) founded in 2012. 908 Devices has raised $68.22 million across 8 funding rounds from investors including SLB, Arch Venture Partners and Sands Capital Ventures. The company has 246 employees as of December 31, 2024. 908 Devices has completed 2 acquisitions, including RedWave Technology and TRACE Analytics. 908 Devices operates in a competitive market with competitors including Refeyn, Advion, Impedimed, Zeteo Tech and Rigaku, among others.
- Headquarter Boston, United States
- Employees 246 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name 908 Devices Inc.
-
Annual Revenue
$59.63 M (USD)18.72as on Dec 31, 2024
-
Net Profit
-$72.21 M (USD)-98.37as on Dec 31, 2024
-
EBITDA
-$28.38 M (USD)29.07as on Dec 31, 2024
-
Total Equity Funding
$68.22 M (USD)
in 8 rounds
-
Latest Funding Round
$17.5 M (USD), Series E
Apr 26, 2019
-
Investors
SLB
& 10 more
-
Employee Count
246
as on Dec 31, 2024
-
Investments & Acquisitions
RedWave Technology
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of 908 Devices
908 Devices is a publicly listed company on the NASDAQ with ticker symbol MASS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of 908 Devices
Unlock access to complete
Unlock access to complete
Advisor Team
16 people
Sales and Marketing
11 people
Leadership Team
9 people
Human Resources and Administration
6 people
Finance and Accounting
5 people
Product Management Team
4 people
Software Development Team
3 people
Legal and Compliance
2 people
Unlock access to complete
Funding Insights of 908 Devices
908 Devices has successfully raised a total of $68.22M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $17.5 million completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in 908 Devices
908 Devices has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include SLB, Arch Venture Partners and Sands Capital Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth stage tech & life sciences focused VC Firm investing in Asia and the US
|
Locked | Locked | Locked | |
|
Venture capital firm focused on life science companies
|
Locked | Locked | Locked | |
|
Multi-stage venture capital investments are made in US sectors.
|
Locked | Locked | Locked |
Investor details for 908 Devices
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by 908 Devices
908 Devices has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include RedWave Technology and TRACE Analytics.
Investment portfolio details for 908 Devices
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of commercial security services
|
Locked | Locked | 2004 | Locked | |
|
Biosensors for online monitoring of biotechnology cultivation processes are developed.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for 908 Devices
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - 908 Devices
Detailed financials for 908 Devices
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
908 Devices Comparisons
Peer comparison for 908 Devices
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of 908 Devices
908 Devices operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Refeyn, Advion, Impedimed, Zeteo Tech and Rigaku, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Single molecular mass measurement technology is developed for biomolecules.
|
|
| Locked | Locked | Locked |
Microfluidics and mass spectrometry products are provided for clinical research.
|
|
| Locked | Locked | Locked |
Technologies for non-invasive fluid status assessment and monitoring are developed.
|
|
| Locked | Locked | Locked |
Biological mass spectrometers are manufactured for airborne microbe detection.
|
|
| Locked | Locked | Locked |
XRD, XRF, SAXS, Raman, metrology, and crystallography solutions are provided.
|
Detailed competitors of 908 Devices
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on 908 Devices
Complete news archive for 908 Devices
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 908 Devices
908 Devices was founded in 2012.
908 Devices is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
908 Devices is a funded company, having raised a total of $68.22M across 8 funding rounds to date.
As of Dec 31, 2024, the latest employee count at 908 Devices is 246.
Annual revenue of 908 Devices is $59.63M as on Dec 31, 2024.
908 Devices was founded in 2012 in Boston, United States, within the biotechnology and chemical analysis sector. Battery-operated, handheld detection tools and personal analyzers are produced for use by biologists and chemists. Mass spectrometry technology is employed in product development for applications including safety and security, food science, biotechnology, clinical diagnostics, and industrial process control. Operations focus on portable solutions for laboratory and field-based chemical analysis.
Yes, 908 Devices is publicly traded on NASDAQ under the ticker symbol MASS.
908 Devices has made 2 acquisitions, including RedWave Technology, and TRACE Analytics.
908 Devices has 11 investors. Key investors include SLB, Arch Venture Partners, Sands Capital Ventures, Razor's Edge Ventures, and Tao Capital Partners.
The ticker symbol of 908 Devices is MASS on NASDAQ.